For example, studies have shown that colchicine, TNF-alpha inhibitors, and cyclosporin A affect the serum levels of miRNAs in BD patients.37–40 Although the medical treatments were not statistically different between BD groups, the serum levels of miR-195 were significantly different in BD patients with vascular involvement. The gene discussed is TNF; the disease is Behcet disease.